Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,636

Document Document Title
WO/2022/170218A1
Disclosed herein are methods of synthesizing compounds of the formula (I) wherein the variables are defined herein. Also provided are compounds produced using these methods. In some aspects, the methods provided herein may be used to ins...  
WO/2022/166993A1
Disclosed in the present invention are a novel boron carrier, a preparation method and a pharmaceutical formulation thereof; in particular, the present invention relates to 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-D]-1,2,3,5-tetrazine-8 -ca...  
WO/2022/161453A1
The present invention provides an organic metal complex and an organic optoelectronic component comprising same, specifically, an organic electroluminescent diode, where the structure of the organic metal complex is as represented by for...  
WO/2021/202536A9
Described herein is an improved wavelength conversion film with composite materials that have improved quantum efficiency and color gamut. The film includes narrow FWHM green and red emitting dyes.  
WO/2022/163377A1
Provided is a photosensitizer which has a specific structure, and has higher sensitivity than existing photosensitizers when light irradiation causes a rapid change from hydrophilicity to hydrophobicity. The present invention pertains to...  
WO/2022/158762A1
An organic electroluminescent device of an embodiment comprises a first electrode, a second electrode, and a light-emitting layer disposed between the first electrode and the second electrode, wherein the light-emitting layer comprises a...  
WO/2022/154114A1
[Problem] To provide a material utilizable as a catalyst for reactions including hydrosilylation. [Solution] Provided is a composite comprising a transition metal complex and a support on which the transition metal complex is supported, ...  
WO/2022/152215A1
Provided is an organic compound, comprising a structure as represented by chemical formula (1). Also provided is an organic mixture, comprising at least one first compound and at least one second compound, wherein the first compound comp...  
WO/2022/150132A1
The present disclosure describes highly soluble activators for use in olefin polymerization processes. These activators are ionic ammonium borates and have the general formula [Ar(ER1R2H)(R3)][tetrakis(perfluoroaryl)borate] where Ar is a...  
WO/2022/144501A1
A tracer compound, or a pharmaceutically acceptable salt or solvate thereof is disclosed, the tracer compound having a structure comprising of a tetrazine moiety, a zwitterion moiety and a linker moiety, the linker moiety linking togethe...  
WO/2022/144228A1
The present invention relates to a compound having formula (I) as well as to the use of such as a dye sensitizer. The present invention also relates to a dye sensitized solar cell comprising at least one compound of formula (I) as dye se...  
WO/2022/145267A1
The present invention is: a thin film-forming starting material for atomic layer deposition, wherein said starting material contains an aluminum compound as represented by general formula (1); a method for producing thin films that uses ...  
WO/2022/145775A1
The present invention relates to: a polycyclic compound represented by chemical formula I; and an organic light emitting device which comprises a first electrode, a second electrode and at least one organic layer provided between the fir...  
WO/2022/145774A1
The present invention provides a novel compound, represented by chemical formula 1, which: can be used as a material for the organic material layer of an organic light emitting device; can be used in a solution process; and can improve l...  
WO/2022/146123A1
The present invention provides a novel compound and an organic light-emitting device comprising same.  
WO/2022/146277A1
The present invention provides usage of boric acid in brittle bone disease treatment. In the present invention, moreover, there is a new brittle bone disease (osteogenesis imperfecta) in-vitro model for observing the effect of boric acid...  
WO/2022/145773A1
The present invention provides a novel compound, expressed by chemical formula 1, that can be used as material for an organic material layer of a light-emitting device as well as in a solution process, the novel compound improving, in th...  
WO/2022/139763A1
The present invention relates to tri(2-dimethyl-R-oxy-silicone) borate compound and synthesis method thereof. More particularly a flame retardant compound which is easy to manufacture, low cost, and suitable for industrial production is ...  
WO/2022/135550A1
Provided are a compound as represented by formula I or a pharmaceutically acceptable salt thereof, and applications of the compound in preparing a medicament for preventing and/or treating a PDE-related disorder.  
WO/2022/138822A1
The present invention relates to an organic electroluminescent element comprising a positive electrode, a negative electrode, a light-emitting layer, and a hole injection layer, wherein: the light-emitting layer is provided between the p...  
WO/2022/133529A1
This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and ...  
WO/2022/139513A1
The present specification provides a compound of formula 1 and an organic light emitting device comprising same.  
WO/2022/135913A1
In particular, the invention relates to a mechanochromic and mechanofluorochromic compound, which has the formula (F) in which: R 1 is selected from: - a linear or branched C1-C4 alkyl chain, and preferably tertiobutyl; a C1-C22 alkoxy c...  
WO/2022/137156A1
The inventive compounds are small molecule therapeutics that are potent inhibitors of arginase 1 and arginase 2 activity. The invention also provides pharmaceutical compositions comprising the compounds, and methods for using the compoun...  
WO/2022/139525A1
The present specification provides an organic light-emitting device comprising an emission layer including: a compound represented by chemical formula 1; and a compound represented by chemical formula H.  
WO/2022/138790A1
A composition for forming a luminescent layer of an organic electroluminescent element that includes a polycyclic heterocyclic compound represented by formula (1), a compound represented by formula (20), and an organic solvent. Provided ...  
WO/2022/129966A1
The present invention relates to a catalytic process for the partial reduction of esters or lactones to silyl acetals, which upon hydrolysis give aldehydes, using silanes as reducing agents, preferably triethylsilane (TESH) or 1,1,3,3-te...  
WO/2022/127193A1
Provided are an electrolyte containing a nitrogen-based salt structure, a preparation method therefor and the use thereof. The electrolyte comprises a boron trifluoride salt, and the structure of the boron trifluoride salt is as shown in...  
WO/2022/133097A1
The disclosure provides processes for preparing spiro derivatives, in particular (2R,5S)-7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)-phenyl]p yrimidin-2-yl]-1,7- diazaspiro[4.4]nonan-6-one, as well as intermediates for use in said proces...  
WO/2022/130796A1
Provided are: a photoacid generator that effectively generates acid even when there is a high concentration of a substance such as a colorant that attenuates or shields irradiated light, and even when the film thickness is great and a li...  
WO/2022/131780A1
The present invention relates to a novel compound having excellent light-emitting ability and to an organic electroluminescent element comprising same. When the compound according to the present invention is used as an organic material l...  
WO/2022/133064A1
Disclosed herein are heterocyclic compounds that inhibit the binding of menin and MLL or MLL fusion proteins. Also described are specific irreversible inhibitors of menin-MLL interaction. Also disclosed are pharmaceutical compositions th...  
WO/2022/131230A1
The purpose of the present invention is to provide a borate compound which is useful as a co-catalyst that is used for polymerization of olefins or dienes. The present invention relates to: a borate compound which is represented by formu...  
WO/2022/129508A1
The present invention concerns a family of organometallic compounds of formula (I) and its use to obtain contrast media applicable in various diagnostic imaging techniques such as X-ray, MRI, PET or SPECT or combinations of these techniq...  
WO/2022/133420A1
The present invention describes novel boron containing pyrazole compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as J...  
WO/2022/131768A1
The present invention relates to a novel compound with an excellent light-emitting capacity, and an organic electroluminescence element comprising same, wherein the compound according to the present invention, when used in an organic mat...  
WO/2022/023496A9
The present invention relates to functionalized isonitrile compounds, formed by means of multicomponent environmentally friendly reactions, suitable for coupling to functional molecules such as biomolecules, APIs, chromophore and fluorop...  
WO/2022/121920A1
Disclosed are a boron-nitrogen compound represented by formula (I) or (II), a composition containing the compound and an application thereof in the field of organic electroluminescence. Also disclosed is a method for preparing a boron-ni...  
WO/2022/121951A1
Disclosed are a boron-nitrogen compound of formula I or II, a composition containing the compound, and the use of the compound and composition in the field of organic electroluminescence. Further disclosed is a method for preparing the b...  
WO/2022/124174A1
Provided are: a metal-containing additive containing a β-diketonatometal complex and having excellent storage stability; a crosslinkable-polymer composition; and a crosslinked-polymer material, a metallic member, and a wire harness whic...  
WO/2022/122431A1
A novel method of making trialkylaluminum compounds and trialkylaluminum obtained thereby via exposing a solution of aluminum to an alkylating agent.  
WO/2022/123530A1
The present invention relates to: a compound represented by chemical formula 1; a pharmaceutically acceptable salt thereof or an isomer thereof; and a pharmaceutical composition for treating or preventing proteasome-borne diseases, conta...  
WO/2022/121224A1
The present invention relates to an organoboron-nitrogen compound, a mixture, a composition and an organic electronic device. The organoboron-nitrogen compound is represented by general formula (I) or (II). The organoboron-nitrogen compo...  
WO/2022/120226A1
The present disclosure provides methods and related compositions that incorporate a molecularly targeted approach via the integrin subtype αvβ6 using Peptide Receptor Radionuclide Therapy (PRRT) and a theranostic approach.  
WO/2022/119297A1
The present invention relates to a polycyclic compound which can be employed in various organic layers included in an organic light emitting device and contains R substituted with at least one deuterium (D), and to an organic light emitt...  
WO/2022/118834A1
An indium compound represented by general formula (1). [Chemical formula 1] (In the formula, R1 and R2 each independently represent an unsubstituted C1-5 alkyl group, etc., R3 and R4 each independently represent a hydrogen atom, an uns...  
WO/2022/116746A1
Disclosed in the present invention is a separation and recovery method for boron trifluoride and a complex thereof in an olefin polymerization reaction. The separation and recovery method comprises: 1) performing flash separation on a mi...  
WO/2022/115417A1
Disclosed herein are NLRP3 inflammasome inhibitors and compositions thereof. Also disclosed herein are methods including administering a therapeutically effective amount of a composition comprising at least one NLRP3 inflammasome inhibit...  
WO/2022/111520A1
The present invention provides an indium-oxygen cluster, a preparation method therefor, a quantum dot prepared therefrom and a preparation method for said quantum dot. The molecular formula of the indium-oxygen cluster is represented by ...  
WO/2022/114333A1
Disclosed is a method for producing of 2-[18F]fluoro-4-boronophenylalanine comprising radioisotopes ([18F]FBPA), the method having a precursor with an effective leaving group and reaction conditions for high-yield synthesis of [18F]FBPA ...  

Matches 1 - 50 out of 7,636